VALEANT PHARMACEUTICALS INTL's ticker is and the CUSIP is 91911K952. A total of 6 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $515,000 | -12.7% | 3,600 | -20.0% | 0.01% | -27.3% |
| Q3 2014 | $590,000 | -64.6% | 4,500 | -65.9% | 0.01% | -57.7% |
| Q2 2014 | $1,665,000 | -66.4% | 13,200 | -64.9% | 0.03% | -58.1% |
| Q1 2014 | $4,957,000 | +44.1% | 37,600 | +28.3% | 0.06% | +63.2% |
| Q4 2013 | $3,440,000 | +29.8% | 29,300 | +15.4% | 0.04% | +11.8% |
| Q3 2013 | $2,650,000 | – | 25,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pentwater Capital Management LP | 3,770,300 | $75,934,000 | 1.01% |
| SIMPLEX TRADING, LLC | 8,247 | $6,549,000 | 0.44% |
| Thrax Management, LLC | 100,000 | $2,014,000 | 0.31% |
| GROUP ONE TRADING, L.P. | 994,600 | $20,031,000 | 0.24% |
| CMT Asset Management Ltd | 192,800 | $3,883,000 | 0.20% |
| Citadel Advisors | 1,838,900 | $37,035,000 | 0.04% |
| JPMORGAN CHASE & CO | 135,000 | $2,719,000 | 0.00% |